Influence of lipoprotein (a) levels and isoforms on fibrinolytic activity -: Study in families with high lipoprotein (a) levels

被引:28
作者
Falcó, C
Estellés, A
Dalmau, J
España, F
Aznar, J
机构
[1] La Fe Univ Hosp, Res Ctr, Valencia, Spain
[2] La Fe Univ Hosp, Childrens Hosp, Valencia, Spain
[3] La Fe Univ Hosp, Dept Clin Pathol, Valencia, Spain
关键词
D O I
10.1055/s-0037-1615071
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Increased levels of lipoprotein (a) [LP(a)] have been considered an independent risk factor for cardiovascular disease, but the mechanism behind this relationship is not completely understood. A high concentration of Lp(a) may interfere with fibrinolysis because of the structural similarity between apo(a) and plasminogen. The aim of the present study was to examine the influence of apo(a) levels and isoforms on fibrinolytic activity in 82 subjects from 24 families in which the Lp(a) levels were greater than or equal to 30 mg/dl in at least one child and one parent. Several fibrinolytic parameters, including plasmin generation by fibrin-bound tissue plasminogen activator, the lipid profile and apo(a) isoforms were studied. Subjects with high circulating Lp(a) levels (n = 44) had significantly reduced plasmin generation compared with their relatives with normal Lp(a) levels (n = 38). A significant inverse correlation between Lp(a) levels and plasmin generation was observed. The individuals with a combination of high levels of plasma Lp(a) and a major apo(a) isoform less than or equal to 580 kD molecular weight show the lowest fibrinolytic activity. A high correlation was found between the levels of apo(a) isoforms in children and the levels of the corresponding parental apo(a) isoforms. We conclude that the antifibrinolytic effect of Lp(a) in subjects with two apo(a) isoforms may depend not only on the total plasma level of Lp(a) but also on the relative concentration of the small apo(a) isoform.
引用
收藏
页码:818 / 823
页数:6
相关论文
共 49 条
[1]   EUGLOBULIN CLOT LYSIS INDUCED BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR IS REDUCED IN SUBJECTS WITH INCREASED LEVELS OF LIPOPROTEIN(A) [J].
AZNAR, J ;
ESTELLES, A ;
BRETO, M ;
ESPANA, F ;
ALOS, T .
THROMBOSIS RESEARCH, 1992, 66 (05) :569-582
[2]   EUGLOBULIN CLOT LYSIS INDUCED BY TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN SUBJECTS WITH INCREASED LEVELS AND DIFFERENT ISOFORMS OF LIPOPROTEIN (A) [J].
AZNAR, J ;
ESTELLES, A ;
BRETO, M ;
ESPANA, F .
THROMBOSIS RESEARCH, 1993, 72 (05) :459-465
[3]  
BAILLEUL S, 1995, CLIN CHEM, V41, P241
[4]  
BERG K, 1963, ACTA PATHOL MIC SC, V59, P369
[5]   LP(A) CONCENTRATION AND APO(A) ISOFORM SIZE - RELATION TO THE PRESENCE OF CORONARY-ARTERY DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA [J].
BOWDEN, JF ;
PRITCHARD, PH ;
HILL, JS ;
FROHLICH, JJ .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (10) :1561-1568
[6]   Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect [J].
Carmena, R ;
LussierCacan, S ;
Roy, M ;
Minnich, A ;
Lingenhel, A ;
Kronenberg, F ;
Davignon, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) :129-136
[7]   PREVALENCE AND EXPRESSION OF FAMILIAL COMBINED HYPERLIPIDEMIA IN CHILDHOOD [J].
CORTNER, JA ;
COATES, PM ;
GALLAGHER, PR .
JOURNAL OF PEDIATRICS, 1990, 116 (04) :514-519
[8]   ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY [J].
DAHLEN, GH ;
GUYTON, JR ;
ATTAR, M ;
FARMER, JA ;
KAUTZ, JA ;
GOTTO, AM .
CIRCULATION, 1986, 74 (04) :758-765
[9]   LIPOPROTEIN-(A) - THE LINK BETWEEN IMPAIRED FIBRINOLYSIS AND ATHEROSCLEROSIS [J].
EDELBERG, JM ;
PIZZO, SV .
FIBRINOLYSIS, 1991, 5 (03) :135-143
[10]   LIPOPROTEIN-ALPHA INHIBITS STREPTOKINASE-MEDIATED ACTIVATION OF HUMAN-PLASMINOGEN [J].
EDELBERT, JM ;
GONZALEZGRONOW, M ;
PIZZO, SV .
BIOCHEMISTRY, 1989, 28 (06) :2370-2374